 5. Patients will not be excluded if they have received 5ASA or an immunomodulator for 8 weeks and the dose is stable , or if they start a thiopurine concurrently , as thiopurines are not considered sufficient to induce remission in active disease before 8 weeks as an isolated therapy. 